ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5 | -28.6% | 1,151 | 0.0% | 0.00% | – |
Q2 2023 | $7 | -22.2% | 1,151 | 0.0% | 0.00% | – |
Q1 2023 | $9 | -25.0% | 1,151 | 0.0% | 0.00% | – |
Q4 2022 | $12 | -99.9% | 1,151 | +8.6% | 0.00% | – |
Q3 2022 | $10,000 | -9.1% | 1,060 | 0.0% | 0.00% | – |
Q2 2022 | $11,000 | +37.5% | 1,060 | +29.0% | 0.00% | – |
Q1 2022 | $8,000 | -33.3% | 822 | 0.0% | 0.00% | – |
Q4 2021 | $12,000 | – | 822 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |